Zhonghui Feng
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Primary Cilia as Integrative Hubs of Metabolic Signaling in Type 2 Diabetes: Inter-Organ Evidence From Central, Peripheral, and Pancreatic Islet Tissues.
Journal: Journal of cellular physiology
Published: May 13, 2026
Adipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling.
Journal: Frontiers in endocrinology
Published: March 04, 2026
Characterization of the gut microbiota in people with different levels of obesity.
Journal: Frontiers in microbiology
Published: August 05, 2025
Dietary vitamin E intake, life expectancy, and mortality risk among adults in the United Kingdom and the United States.
Journal: International journal of surgery (London, England)
Published: July 29, 2025
Identifying gut microbiota Faecalibacterium as a potential biomarker for distinguishing visceral or subcutaneous obese population.
Journal: Frontiers in microbiology
Published: May 27, 2025
Prevotella copri leads to colonic barrier dysfunction via the succinate receptor 1-FoxM1-IL-6 axis.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 01, 2025
Prevotella copri promotes white adipose browning and ameliorates adiposity.
Journal: Nature communications
Published: November 18, 2024
Integrated Transcriptomics and Proteomics Identified CMPK1 as a Potential Biomarker for Type 2 Diabetes Mellitus.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 07, 2024
Exploring flavonoid intake and all-cause mortality in diverse health conditions: Insights from NHANES 2007-2010 and 2017-2018.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: February 29, 2024
Skeletal muscle mass is a strong predictor of cardiorespiratory fitness in the Chinese population with obesity.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: December 21, 2022
Lidocaine ameliorates intestinal barrier dysfunction in irritable bowel syndrome by modulating corticotropin-releasing hormone receptor 2.
Journal: Neurogastroenterology and motility
Published: August 13, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026